| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| YoY growth | +31.0% | ||||||
| Cost of revenue | |||||||
| Gross profit | |||||||
| % of revenue | 23.0% | ||||||
| Operating expenses: | |||||||
| Sales and marketing | |||||||
| Research and development | |||||||
| General and administrative | |||||||
| Transaction expenses | |||||||
| Total operating expenses | |||||||
| % of revenue | 45.6% | ||||||
| Loss from operations | |||||||
| % of revenue | -22.6% | ||||||
| Interest (expense) income, net | |||||||
| Gain (loss) on disposal of assets | |||||||
| Gain (loss) on fair value remeasurement of contingent consideration | |||||||
| Change in fair value of derivative warrant liabilities | |||||||
| Loss on abandonment of assets | |||||||
| Gain (loss) on foreign currency | |||||||
| Total other income (expense) | |||||||
| Loss before income taxes | |||||||
| Income tax benefit (expense) | |||||||
| Gain from equity method investment | |||||||
| Net loss | |||||||
| % of revenue | -16.7% | ||||||
| Loss per share attributable to common stockholders: | |||||||
| Basic | |||||||
| Diluted |